Correlation Between Brightsphere Investment and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Brightsphere Investment and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brightsphere Investment and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Brightsphere Investment Group and Neurocrine Biosciences, you can compare the effects of market volatilities on Brightsphere Investment and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brightsphere Investment with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brightsphere Investment and Neurocrine Biosciences.

Diversification Opportunities for Brightsphere Investment and Neurocrine Biosciences

0.78

Correlation Coefficient

Brightsphere Investment  Neurocrine Biosciences

Poor diversification

The 3 months correlation between Brightsphere and Neurocrine is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Brightsphere Investment Group and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Brightsphere Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brightsphere Investment Group are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Brightsphere Investment i.e., Brightsphere Investment and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Brightsphere Investment and Neurocrine Biosciences

Given the investment horizon of 90 days Brightsphere Investment Group is expected to under-perform the Neurocrine Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Brightsphere Investment Group is 1.04 times less risky than Neurocrine Biosciences. The stock trades about -0.45 of its potential returns per unit of risk. The Neurocrine Biosciences is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  12,565  in Neurocrine Biosciences on September 23, 2024 and sell it today you would earn a total of  977.00  from holding Neurocrine Biosciences or generate 7.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Brightsphere Investment Group  vs.  Neurocrine Biosciences

Brightsphere Investment

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Brightsphere Investment Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, Brightsphere Investment may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Neurocrine Biosciences

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Brightsphere Investment and Neurocrine Biosciences

The main advantage of trading using opposite Brightsphere Investment and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brightsphere Investment position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Brightsphere Investment Group and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.